DLHC

DLHC is a $77M-market-cap federal services contractor that the market is pricing for stress — 0.2x sales and roughly 3.3x operating cash flow ($23.2M OCF on a $76.8M cap). The headline 58.9x P/E is noise: GAAP net income ($1.36M) is crushed by interest on a heavy debt load and ~$17.2M of acquisition-related D&A, so the cash story is far better than the earnings story. Operating income was still $16.8M (4.9% margin) and EBITDA (op income + D&A) is ~$34M, putting enterprise value (cap + ~$128M debt − $0.1M cash) near 6x EBITDA. Management is using that cash to deleverage — long-term debt fell 12.6% to $120M and the current portion dropped 33% — which is the right priority and the core of the bull case.

The problem is the trajectory and the customer. Revenue fell 13% to $344M and net income collapsed 81.6%; operating income itself was down 32.6%. The MD&A is explicit that this is not noise: the company derives 99% of revenue from the Federal government (HHS 49.8%, VA 33.8%, DoD 15.5%), and administration spending reviews have 'already led to some contract reductions, cancellations, and price renegotiations,' with 'future reviews' flagged to cause more. A government shutdown ran Oct 1–Nov 12 2025 and the stop-gap CR only funds through Jan 30 2026 — so appropriations risk is recurring and current. With half of revenue tied to a single agency (HHS) being targeted for 'efficiency,' concentration risk is acute.